| Diabetic dyslipidemia: extending the target beyond LDL cholesterol. | |
| | |
MedLine Citation:
|
PMID: 20489416 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Lowering low-density lipoprotein cholesterol plays an important role in therapeutic strategies designed to reduce cardiovascular risk. However, the residual clinical risk in statin trials suggests that additional therapies will be required to achieve more effective prevention of cardiovascular disease. The high prevalence of hypertriglyceridemia and low levels of high-density lipoprotein cholesterol in diabetes presents further targets for the development of new cardioprotective therapies. |
| | |
Authors:
|
Stephen J Nicholls; Pia Lundman; Jean-Claude Tardif |
Related Documents
:
|
16325036 - Stabilization of carotid atheroma assessed by quantitative ultrasound analysis in nonhy... 17901546 - Plasma 24s hydroxycholesterol response to statins in alzheimer's disease patients: effe... 19552506 - Update on patented cholesterol absorption inhibitors. 17142146 - Lipoprotein effects of combined ezetimibe and colesevelam hydrochloride versus ezetimib... 1402476 - Effect of vegetable oil intake on erythrocyte physical properties and hemorheology. 18495466 - Carbohydrate restriction and dietary cholesterol distinctly affect plasma lipids and li... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology Volume: 17 Suppl 1 ISSN: 1741-8275 ISO Abbreviation: Eur J Cardiovasc Prev Rehabil Publication Date: 2010 May |
Date Detail:
|
Created Date: 2010-05-21 Completed Date: 2010-08-30 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101192000 Medline TA: Eur J Cardiovasc Prev Rehabil Country: England |
Other Details:
|
Languages: eng Pagination: S20-4 Citation Subset: IM |
Affiliation:
|
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH 44195, USA. nichols1@ccf.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antilipemic Agents
/
therapeutic use* Biological Markers / blood Cardiovascular Diseases / blood, etiology, prevention & control* Cholesterol, HDL / blood Cholesterol, LDL / blood* Diabetes Complications / blood, drug therapy*, etiology Diabetes Mellitus, Type 2 / blood, complications, drug therapy* Dyslipidemias / blood, drug therapy*, etiology Humans Treatment Outcome Triglycerides / blood |
| Chemical | |
Reg. No./Substance:
|
0/Antilipemic Agents; 0/Biological Markers; 0/Cholesterol, HDL; 0/Cholesterol, LDL; 0/Triglycerides |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Hyperglycaemia and the vessel wall: the pathophysiological aspects on the atherosclerotic burden in ...
Next Document: Glucose lowering and cardiovascular disease: what do we know and what should we do?